艾弗梅克抑制膀癌细胞生长,并诱导氧化应激和DNA损伤
Ning Fan1, Lixiu Zhang2, Zhiping Wang1
1Institute of Urology, Key Laboratory of Gansu Urological Diseases, Gansu Nephro-Urological Clinical Center, Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730030, China.
Anti-cancer agents in medicinal chemistry
|February 20, 2024
概括
抗寄生虫药物伊弗麦丁在体外和体内都能有效抑制膀癌细胞的生长. 这项研究证明了其作为一种新型治疗剂的潜力,通过诱导癌细胞的亡和DNA损伤来证明其潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 膀癌是一种普遍存在的尿道系统恶性瘤,治疗选择有限.
- 对于有效的膀癌管理,迫切需要新的治疗策略.
研究的目的:
- 为了研究一种广泛的抗寄生虫药物 - - 伊弗梅克丁 - - 对膀癌的抗癌作用.
- 为了评估IVERMECTIN在体外和体外的疗效.
主要方法:
- 用CCK-8和EDU测定来评估细胞增殖.
- 通过流细胞计,TUNEL测定,西部抹杀和彗星测定分析了亡,反应性氧物种 (ROS) 水平和DNA损伤.
- 裸体小鼠的异种移植瘤模型被用于体内评估.
主要成果:
- 伊弗梅克在体外和体内都显示出明显抑制膀癌细胞生长.
- 伊弗梅克诱导了亡,增加了ROS的产生,并导致膀癌细胞的DNA受损.
- 与ATM/P53通路相关的蛋白质被Ivermectin治疗激活.
结论:
- 艾弗梅克对膀癌具有强大的抗癌特性.
- 甲胺显示出作为膀癌治疗的潜在治疗候选人的承诺.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Mutations
37.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
37.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


